201 related articles for article (PubMed ID: 7794580)
1. In situ hybridization shows increased endothelin-1 mRNA levels in endothelial cells of blood vessels of deoxycorticosterone acetate-salt hypertensive rats.
Day R; Larivière R; Schiffrin EL
Am J Hypertens; 1995 Mar; 8(3):294-300. PubMed ID: 7794580
[TBL] [Abstract][Full Text] [Related]
2. Vascular and cardiac overexpression of endothelin-1 gene in one-kidney, one clip Goldblatt hypertensive rats but only in the late phase of two-kidney one clip Goldblatt hypertension.
Sventek P; Turgeon A; García R; Schiffrin EL
J Hypertens; 1996 Jan; 14(1):57-64. PubMed ID: 12013496
[TBL] [Abstract][Full Text] [Related]
3. Enhanced expression of endothelin-1 gene may cause blood pressure-independent vascular hypertrophy.
Schiffrin EL; Larivière R; Li JS; Sventek P; Touyz RM
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S5-8. PubMed ID: 8587458
[TBL] [Abstract][Full Text] [Related]
4. Increased endothelin-1 gene expression in the endothelium of coronary arteries and endocardium in the DOCA-salt hypertensive rat.
Larivière R; Deng LY; Day R; Sventek P; Thibault G; Schiffrin EL
J Mol Cell Cardiol; 1995 Oct; 27(10):2123-31. PubMed ID: 8576929
[TBL] [Abstract][Full Text] [Related]
5. Localization of sites of enhanced expression of endothelin-1 in the kidney of DOCA-salt hypertensive rats.
Deng LY; Day R; Schiffrin EL
J Am Soc Nephrol; 1996 Aug; 7(8):1158-64. PubMed ID: 8866407
[TBL] [Abstract][Full Text] [Related]
6. Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms.
Callera GE; Tostes RC; Yogi A; Montezano AC; Touyz RM
Clin Sci (Lond); 2006 Feb; 110(2):243-53. PubMed ID: 16271043
[TBL] [Abstract][Full Text] [Related]
7. Involvement of endothelin-1 in deoxycorticosterone acetate-salt-induced hypertension and cardiovascular hypertrophy.
Matsumura Y; Fujita K; Miyazaki Y; Takaoka M; Morimoto S
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S456-8. PubMed ID: 8587444
[TBL] [Abstract][Full Text] [Related]
8. Endothelin-1 expression in blood vessels of DOCA-salt hypertensive rats treated with the combined ETA/ETB endothelin receptor antagonist bosentan.
Larivière R; Sventek P; Thibault G; Schiffrin EL
Can J Physiol Pharmacol; 1995 Mar; 73(3):390-8. PubMed ID: 7544236
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of endothelin-1 gene in blood vessels of deoxycorticosterone acetate-salt hypertensive rats.
Larivière R; Day R; Schiffrin EL
Hypertension; 1993 Jun; 21(6 Pt 2):916-20. PubMed ID: 8505101
[TBL] [Abstract][Full Text] [Related]
10. Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats.
Larivière R; Thibault G; Schiffrin EL
Hypertension; 1993 Mar; 21(3):294-300. PubMed ID: 8478038
[TBL] [Abstract][Full Text] [Related]
11. Enhanced expression of the endothelin-1 gene in blood vessels of DOCA-salt hypertensive rats: correlation with vascular structure.
Schiffrin EL; Larivière R; Li JS; Sventek P
J Vasc Res; 1996; 33(3):235-48. PubMed ID: 8924521
[TBL] [Abstract][Full Text] [Related]
12. Endothelin: role in hypertension.
Schiffrin EL
Biol Res; 1998; 31(3):199-208. PubMed ID: 9830507
[TBL] [Abstract][Full Text] [Related]
13. Endothelin in hypertension.
Schiffrin EL
Curr Opin Cardiol; 1995 Sep; 10(5):485-94. PubMed ID: 7496057
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-1 gene expression and vascular hypertrophy in DOCA-salt hypertension compared to spontaneously hypertensive rats.
Schiffrin EL; Lariviere R; Li JS; Sventek P; Touyz RM
Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S188-90. PubMed ID: 9072349
[TBL] [Abstract][Full Text] [Related]
15. A proteasome inhibitor prevents vascular hypertrophy in deoxycorticosterone acetate-salt hypertensive rats.
Takaoka M; Ohkita M; Itoh M; Kobayashi Y; Okamoto H; Matsumura Y
Clin Exp Pharmacol Physiol; 2001; 28(5-6):466-8. PubMed ID: 11380524
[TBL] [Abstract][Full Text] [Related]
16. Gene transfer of human guanosine 5'-triphosphate cyclohydrolase I restores vascular tetrahydrobiopterin level and endothelial function in low renin hypertension.
Zheng JS; Yang XQ; Lookingland KJ; Fink GD; Hesslinger C; Kapatos G; Kovesdi I; Chen AF
Circulation; 2003 Sep; 108(10):1238-45. PubMed ID: 12925450
[TBL] [Abstract][Full Text] [Related]
17. Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy.
Li JS; Larivière R; Schiffrin EL
Hypertension; 1994 Aug; 24(2):183-8. PubMed ID: 8039842
[TBL] [Abstract][Full Text] [Related]
18. Deoxycorticosterone acetate plus salt induces overexpression of vascular endothelin-1 and severe vascular hypertrophy in spontaneously hypertensive rats.
Schiffrin EL; Larivière R; Li JS; Sventek P; Touyz RM
Hypertension; 1995 Apr; 25(4 Pt 2):769-73. PubMed ID: 7721430
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of receptor-operated cation current and TRPC6 expression in arterial smooth muscle cells of deoxycorticosterone acetate-salt hypertensive rats.
Bae YM; Kim A; Lee YJ; Lim W; Noh YH; Kim EJ; Kim J; Kim TK; Park SW; Kim B; Cho SI; Kim DK; Ho WK
J Hypertens; 2007 Apr; 25(4):809-17. PubMed ID: 17351373
[TBL] [Abstract][Full Text] [Related]
20. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
Li JS; Turgeon A; Schiffrin EL
Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
